Pediatric Neurology Briefs (Dec 2007)

Sustained Benefit of 6-Month Topiramate Treatment for Migraine

  • J Gordon Millichap

DOI
https://doi.org/10.15844/pedneurbriefs-21-12-4
Journal volume & issue
Vol. 21, no. 12
pp. 91 – 92

Abstract

Read online

The effects of discontinuing topiramate after a treatment period of 6 months in 818 patients with migraine, enrolled from 88 clinics in 21 countries in Europe, the UK and Turkey, are reported from University Duisburg-Essen, Germany.

Keywords